Penumbra

Yahoo Finance • last month

Penumbra, Corcept, Elanco, ResMed, and LeMaitre Stocks Trade Up, What You Need To Know

What Happened? A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated he sees “room for a fu... Full story

Yahoo Finance • 2 months ago

Bullish Two Hundred Day Moving Average Cross - PEN

In trading on Monday, shares of Penumbra Inc (Symbol: PEN) crossed above their 200 day moving average of $175.34, changing hands as high as $179.68 per share. Penumbra Inc shares are currently trading up about 10.2% on the day. The chart... Full story

Yahoo Finance • 2 months ago

Penumbra raises 2025 revenue guidance to $1.375B–$1.38B as CAVT and embolization drive growth

Earnings Call Insights: Penumbra, Inc. (PEN) Q3 2025 MANAGEMENT VIEW * Adam Elsesser, Co-Founder, Chairman & CEO, opened by stating, "In the third quarter, we generated total revenue of $354.7 million, representing underlying year-over... Full story

Yahoo Finance • 2 months ago

Penumbra Enters Oversold Territory (PEN)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the R... Full story

Yahoo Finance • 3 months ago

Penumbra upgraded at Needham on revenue growth acceleration

[Wall Street in New York City] JaysonPhotography/iStock via Getty Images * Needham has upgraded Penumbra (NYSE:PEN [https://seekingalpha.com/symbol/PEN]) to buy from hold as it sees a boost in revenue growth in 2026. * The firm set a... Full story

Yahoo Finance • 3 months ago

Intel, FedEx downgraded: Wall Street's top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: Deutsche Bank upgraded Northrop Grumma... Full story

Yahoo Finance • 3 months ago

After-Hours Movers: Biotech And Medtech Stocks Jump On Volume And News

(RTTNews) - A wave of after-hours activity swept through select biotech and medical device names Thursday, with several micro- and mid-cap stocks posting sharp gains following session-end catalysts, volume spikes, or pipeline updates. Belo... Full story

Yahoo Finance • 3 months ago

Deutsche Bank’s ‘Conviction list’ for Q4: KO, SCHW, LLY and more

[Journey of Distinction - Gradient Spheres Tapering Along Steps to a Singular Summit] J Studios/DigitalVision via Getty Images Deutsche Bank’s research team selected their top investment ideas to hold over the next 12 months, with new pic... Full story

Yahoo Finance • 4 months ago

Penumbra names Shruthi Narayan as president, effective September 1

* Penumbra (NYSE:PEN [https://seekingalpha.com/symbol/PEN]) announced on Wednesday the promotion of Shruthi Narayan to President, effective September 1, 2025. * Ms. Narayan was most recently president of Penumbra's interventional busi... Full story

Yahoo Finance • 4 months ago

Yuen, Penumbra CFO, sells $500k in shares

Penumbra Inc. (NASDAQ:PEN) Chief Financial Officer Maggie Yuen sold 2,000 shares of common stock on August 13, 2025, at a price of $250.0, totaling $500,000. The sale was executed under a Rule 10b5-1 trading plan. The medical devices compa... Full story

Yahoo Finance • 4 months ago

Arani Bose sells Penumbra shares worth $3m

Director Arani Bose sold 12,000 shares of Penumbra Inc (NASDAQ:PEN) common stock on August 13, 2025, for approximately $3,007,775. The transaction comes as Penumbra, with a market capitalization of $9.84 billion, maintains a "GREAT" financ... Full story

Yahoo Finance • 4 months ago

Penumbra Inc director Wilder sells $89k in stock

Director Thomas Wilder of Penumbra Inc (NYSE:PEN), a medical devices company with a market capitalization of $10.07 billion, sold 372 shares of common stock on August 12, 2025, at a price of $240.16, for a total value of $89,339. The stock... Full story

Yahoo Finance • 5 months ago

Should You Invest in Penumbra (PEN)?

Baron Funds, an investment management company, released its “Baron Health Care Fund” second-quarter 2025 investor letter. A copy of the letter can be downloaded here. The fund declined 5.06% (Institutional Shares) in the quarter, against a... Full story

Yahoo Finance • 5 months ago

PEN Makes Bullish Cross Above Critical Moving Average

In trading on Wednesday, shares of Penumbra Inc (Symbol: PEN) crossed above their 200 day moving average of $268.52, changing hands as high as $271.50 per share. Penumbra Inc shares are currently trading up about 4.3% on the day. The cha... Full story

Yahoo Finance • 5 months ago

Penumbra outlines 13% to 15% revenue growth target for 2025 as thrombectomy adoption accelerates

Earnings Call Insights: Penumbra, Inc. (PEN) Q2 2025 MANAGEMENT VIEW * Adam Elsesser, Chairman and CEO, reported, "In the second quarter, we generated total revenue of $339.5 million, representing underlying year-over-year growth of 13... Full story

Yahoo Finance • 5 months ago

Penumbra Inc (NYSE:PEN) Surpasses Q2 2025 Earnings and Revenue Estimates Amid Market Challenges

Penumbra Inc (NYSE:PEN [https://www.chartmill.com/stock/quote/PEN/profile]) reported its second-quarter 2025 financial results, surpassing analyst expectations for both revenue and earnings per share (EPS). The company, a leader in thrombe... Full story

Yahoo Finance • 5 months ago

Notable Tuesday Option Activity: TDOC, PEN, CMA

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Teladoc Health Inc (Symbol: TDOC), where a total of 35,424 contracts have traded so far, representing approximately 3.5 million un... Full story

Yahoo Finance • 5 months ago

Penumbra CEO Adam Elsesser sells $3.7m in shares

Penumbra Inc (NASDAQ:NYSE:PEN) CEO and President Adam Elsesser sold a total of 15,150 shares of common stock on July 23, 2025, for approximately $3.7 million. The sales were executed in multiple transactions with prices ranging from $232.... Full story

Yahoo Finance • 5 months ago

Analysis-Five years after COVID, pharma shares languish in US policy limbo

By Danilo Masoni MILAN (Reuters) -Global healthcare stocks have not been this cheap in decades and fund inflows into the sector are picking up, yet the shares remain in the doldrums, highlighting uncertainty over drug pricing policies sin... Full story

Yahoo Finance • 5 months ago

Penumbra CEO Elsesser sells $3.89m in shares

Penumbra Inc (NASDAQ:NYSE:PEN) CEO and President Adam Elsesser sold a total of 14,975 shares of common stock on July 9, 2025, for approximately $3.89 million. The sales were executed at prices ranging from $241.09 to $248.79. According to... Full story